Mental health, psychotropic medication use, and menstrual cycle characteristics

被引:36
作者
Nillni, Yael I. [1 ,2 ]
Wesselink, Amelia K. [3 ]
Hatch, Elizabeth E. [3 ]
Mikkelsen, Ellen M. [4 ]
Gradus, Jaimie L. [1 ,2 ,3 ]
Rothman, Kenneth J. [3 ,5 ]
Wise, Lauren A. [3 ]
机构
[1] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA
[2] VA Boston Healthcare Syst, Natl Ctr PTSD, Womens Hlth Sci Div, Boston, MA USA
[3] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA
[4] Aarhus Univ, Dept Clin Epidemiol, Aarhus, Denmark
[5] RTI Hlth Solut, Res Triangle Pk, NC USA
来源
CLINICAL EPIDEMIOLOGY | 2018年 / 10卷
关键词
depression; menstrual cycle irregularity; perceived stress; psychotropic medication; MAJOR DEPRESSION INVENTORY; PSYCHIATRIC-DISORDERS; PROSPECTIVE-COHORT; PERCEIVED STRESS; RISK; AXIS; FECUNDABILITY; PREGNANCY; CORTISOL; VALIDITY;
D O I
10.2147/CLEP.S152131
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose: To examine the influence of depressive symptoms, perceived stress, and psychotropic medication use on prospectively assessed menstrual cycle regularity and length. Participants and methods: Data were obtained from Pregnancy Study Online, a prospective cohort study of pregnancy planners from North America. At baseline, women reported information on demographics, anthropometrics, lifestyle, and medical history, including their use of psychotropic medications. They also completed the Major Depression Inventory and the Perceived Stress Scale. Every 8 weeks for up to 12 months or until conception, women completed follow-up questionnaires to assess changes in psychotropic medication use, perceived stress, and menstrual cycle characteristics (ie, cycle regularity and length). Women who completed at least one follow-up questionnaire from 2013 to 2018 (n=3,346) were included in the primary analyses. A total of 5,439 women were included in secondary analyses utilizing baseline data only. Primary analyses estimated prevalence ratios (PR) and 95% CIs using log-binomial regression models. Results: Women with severe depressive symptoms at baseline, regardless of psychotropic medication use, had an 80% greater prevalence of irregular cycles during follow-up than women with no or low depressive symptoms (PR = 1.80, 95% CI = 1.48-2.19). Perceived stress was also associated with the prevalence of irregular cycles during follow-up (PR = 1.33, 95% CI = 1.14-1.55). Psychotropic medication use was not appreciably associated with menstrual characteristics after controlling for history of diagnosed depression and/or anxiety. Depressive symptoms, perceived stress, and psychotropic medication use showed little association with menstrual cycle length. Conclusion: Higher levels of depressive symptoms and perceived stress were associated with irregular menstrual cycles, but not appreciably associated with menstrual cycle length. Use of psychotropic medications was not meaningfully associated with cycle regularity or length.
引用
收藏
页码:1073 / 1082
页数:10
相关论文
共 50 条
  • [1] The impact of COVID-19-related mental health issues on menstrual cycle characteristics of female healthcare providers
    Takmaz, Taha
    Gundogmus, Ibrahim
    Okten, Sabri Berkem
    Gunduz, Anil
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2021, 47 (09) : 3241 - 3249
  • [2] The association between mental illness, psychotropic medication use and hypertensive disorders in pregnancy: A multicentre study
    Frayne, Jacqueline
    Watson, Stuart
    Snellen, Martien
    Nguyen, Thinh
    Galbally, Megan
    PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH, 2021, 24 : 22 - 26
  • [3] Psychotropic medication use for paediatric mental health patients in an emergency department
    O'Donnell, Sinead M.
    Carison, Anna
    Hill, Ashley
    Say, Daniela
    Hiscock, Harriet
    Babl, Franz E.
    EMERGENCY MEDICINE AUSTRALASIA, 2021, 33 (02) : 292 - 301
  • [4] Mental Health Disorders and Psychotropic Medication: Prevalence and Related Characteristics Among Individuals in Foster Care
    McLeigh, Jill D. D.
    Malthaner, Lauren Q. Q.
    Tovar, Madeline C. C.
    Khan, Mohsin
    JOURNAL OF CHILD & ADOLESCENT TRAUMA, 2023, 16 (03) : 745 - 757
  • [5] Use of a Computerized Medication Shared Decision Making Tool in Community Mental Health Settings: Impact on Psychotropic Medication Adherence
    Stein, Bradley D.
    Kogan, Jane N.
    Mihalyo, Mark J.
    Schuster, James
    Deegan, Patricia E.
    Sorbero, Mark J.
    Drake, Robert E.
    COMMUNITY MENTAL HEALTH JOURNAL, 2013, 49 (02) : 185 - 192
  • [6] Psychotropic medication profile in a community youth mental health service in Australia
    Dharni, Aprajita
    Coates, Dominiek
    CHILDREN AND YOUTH SERVICES REVIEW, 2018, 90 : 8 - 14
  • [7] Educational level and the use of mental health services, psychotropic medication and psychotherapy among adults with a history of physician diagnosed mental disorders
    Halme, Marie
    Rautava, Paivi
    Sillanmaki, Lauri
    Sumanen, Markku
    Suominen, Sakari
    Vahtera, Jussi
    Virtanen, Pekka
    Salo, Paula
    INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY, 2023, 69 (02) : 493 - 502
  • [8] Depression, anxiety, and psychotropic medication use and fecundability
    Nillni, Yael I.
    Wesselink, Amelia K.
    Gradus, Jaimie L.
    Hatch, Elizabeth E.
    Rothman, Kenneth J.
    Mikkelsen, Ellen M.
    Wise, Lauren A.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 215 (04)
  • [9] Fear of childbirth, mental health, and medication use during pregnancy
    Nordeng, Hedvig
    Hansen, Cathrine
    Garthus-Niegel, Susan
    Eberhard-Gran, Malin
    ARCHIVES OF WOMENS MENTAL HEALTH, 2012, 15 (03) : 203 - 209
  • [10] Mental Health Disorders and Psychotropic Medication: Prevalence and Related Characteristics Among Individuals in Foster Care
    Jill D. McLeigh
    Lauren Q. Malthaner
    Madeline C. Tovar
    Mohsin Khan
    Journal of Child & Adolescent Trauma, 2023, 16 : 745 - 757